139 related articles for article (PubMed ID: 26462877)
21. Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma.
Al-Tahan A; Sarkis O; Harajly M; Baghdadi OK; Zibara K; Boulos F; Dighe D; Kregel S; Bazarbachi A; El-Sabban M; Skapek SX; Saab R
Pediatr Blood Cancer; 2012 Jun; 58(6):877-84. PubMed ID: 21755593
[TBL] [Abstract][Full Text] [Related]
22. The Fem1a gene is downregulated in Rhabdomyosarcoma.
Ventura-Holman T; Hahn H; Subauste JS; Maher JF
Tumour Biol; 2005; 26(6):294-9. PubMed ID: 16254458
[TBL] [Abstract][Full Text] [Related]
23. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
24. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ
Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678
[TBL] [Abstract][Full Text] [Related]
25. The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model.
Machado I; Mayordomo-Aranda E; Giner F; Llombart-Bosch A
Fetal Pediatr Pathol; 2015; 34(5):271-81. PubMed ID: 26125949
[TBL] [Abstract][Full Text] [Related]
26. Expression of myogenic regulating factors, Myogenin and MyoD, in two canine botryoid rhabdomyosarcomas.
Kobayashi M; Sakai H; Hirata A; Yonemaru K; Yanai T; Watanabe K; Yamazoe K; Kudo T; Masegi T
Vet Pathol; 2004 May; 41(3):275-7. PubMed ID: 15133178
[TBL] [Abstract][Full Text] [Related]
27. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.
Taulli R; Bersani F; Foglizzo V; Linari A; Vigna E; Ladanyi M; Tuschl T; Ponzetto C
J Clin Invest; 2009 Aug; 119(8):2366-78. PubMed ID: 19620785
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.
Ishiguro N; Motoi T; Osaki M; Araki N; Minamizaki T; Moriyama M; Ito H; Yoshida H
Hum Pathol; 2005 Jun; 36(6):620-5. PubMed ID: 16021567
[TBL] [Abstract][Full Text] [Related]
29. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development.
Lin YC; Kuo MW; Yu J; Kuo HH; Lin RJ; Lo WL; Yu AL
Mol Biol Evol; 2008 Oct; 25(10):2189-98. PubMed ID: 18667440
[TBL] [Abstract][Full Text] [Related]
30. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
[TBL] [Abstract][Full Text] [Related]
31. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
[TBL] [Abstract][Full Text] [Related]
32. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma.
Miyachi M; Tsuchiya K; Yoshida H; Yagyu S; Kikuchi K; Misawa A; Iehara T; Hosoi H
Biochem Biophys Res Commun; 2010 Sep; 400(1):89-93. PubMed ID: 20696132
[TBL] [Abstract][Full Text] [Related]
33. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma.
Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S
Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells.
Ricaud S; Vernus B; Duclos M; Bernardi H; Ritvos O; Carnac G; Bonnieu A
Oncogene; 2003 Nov; 22(51):8221-32. PubMed ID: 14614446
[TBL] [Abstract][Full Text] [Related]
36. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
[TBL] [Abstract][Full Text] [Related]
37. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
38. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
39. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.
Chen SL; Dowhan DH; Hosking BM; Muscat GE
Genes Dev; 2000 May; 14(10):1209-28. PubMed ID: 10817756
[TBL] [Abstract][Full Text] [Related]
40. R-Cadherin expression inhibits myogenesis and induces myoblast transformation via Rac1 GTPase.
Kucharczak J; Charrasse S; Comunale F; Zappulla J; Robert B; Teulon-Navarro I; Pèlegrin A; Gauthier-Rouvière C
Cancer Res; 2008 Aug; 68(16):6559-68. PubMed ID: 18701479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
